The PE Ratio as of September 2024 (TTM) for Invivyd, Inc. (IVVD) is -0.45

According to Invivyd, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.45. This represents a change of -71.13% compared to the average of -1.56 of the last 4 quarters.

Invivyd, Inc. (IVVD) Historical PE Ratio (quarterly & annually)

How has IVVD PE Ratio performed in the past?

The mean historical PE Ratio of Invivyd, Inc. over the last ten years is -10.46. The current -0.45 PE Ratio has changed 330.02% with respect to the historical average. Over the past ten years (40 quarters), IVVD's PE Ratio was at its highest in in the December 2020 quarter at -0.46. The PE Ratio was at its lowest in in the June 2020 quarter at -1132.05.

Invivyd, Inc. (IVVD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Invivyd, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Invivyd, Inc. (IVVD) Average PE Ratio

How has IVVD PE Ratio performed in the past?

The current PE Ratio of Invivyd, Inc. (IVVD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Invivyd, Inc. (IVVD) PE Ratio vs. Peers

How is IVVD’s PE Ratio compared to its peers?

Invivyd, Inc.’s PE Ratio is less than Exscientia plc (0), greater than Recursion Pharmaceuticals, Inc. (-3.65), greater than Atea Pharmaceuticals, Inc. (-3.82), greater than Unity Biotechnology, Inc. (-1.72), greater than Icosavax, Inc. (-0.79), greater than REGENXBIO Inc. (-8.27), greater than Anebulo Pharmaceuticals, Inc. (-2.41), greater than Abeona Therapeutics Inc. (-4.99), greater than Black Diamond Therapeutics, Inc. (-4.22), greater than Generation Bio Co. (-3.70), greater than Kronos Bio, Inc. (-0.92), greater than Erasca, Inc. (-0.58), greater than C4 Therapeutics, Inc. (-3.94), greater than Edgewise Therapeutics, Inc. (-3.44), greater than Passage Bio, Inc. (-14.14), greater than Magenta Therapeutics, Inc. (-0.57), less than TRACON Pharmaceuticals, Inc. (-0.04), less than Aptevo Therapeutics Inc. (0.03), less than null (-0.05),

Build a custom stock screener for Invivyd, Inc. (IVVD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Invivyd, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Invivyd, Inc. (IVVD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Invivyd, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.